Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHD

Clinical trial NCT00418262 · COMPLETED

Trial details

NCT number: NCT00418262
Sponsor: University of Oklahoma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Fetal Alcohol Syndrome Attention Deficit Hyperactivity Disorder (ADHD)

Start date: 2005-08-01
Primary completion: 2015-04-22
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.